Asthma Remote Monitoring Platform

About myBiometry

myBiometry is a private, pre-revenue US digital health startup founded in 2019, building an integrated platform for asthma management. The company's solution centers on a patented at-home FeNO sensor and a companion app that aggregates biomarker, clinical, and environmental data to generate predictive risk models and deliver automated, guideline-based coaching. Led by a seasoned team with medical device and diagnostics expertise, myBiometry aims to shift asthma care from reactive symptom management to proactive, biologically-informed prevention, though its technology is still in development and not yet FDA-cleared.

Therapeutic Areas